As filed with the Securities and Exchange Commission on July 19, 2000

                                                    Registration No. 333-40712

                     SECURITIES AND EXCHANGE COMMISSION
                           WASHINGTON, D.C. 20549

                             AMENDMENT NO. 1
                                   TO
                                 FORM S-3
                          REGISTRATION STATEMENT
                                  UNDER
                        THE SECURITIES ACT OF 1933
                             _________________

                              PHOTRONICS, INC.
         (Exact name of registrant as specified in its charter)


Connecticut                           3559                     06-0854886
(State or other      (Primary Standard Industrial        (I.R.S. Employer
jurisdiction         Classification Code Number)       Identification No.)
of incorporation)

                                   1061 East Indiantown Road
                                    Jupiter, Florida  33477
                                         (561) 745-1222
                      (Address, including zip code, and telephone number,
              including area code, of registrant's principal executive offices)

                                   Jeffrey P. Moonan, Esq.
                       Executive Vice President and General Counsel
                                      Photronics, Inc.
                                       15 Sector Road
                              Brookfield, Connecticut  06804


                                          Copies to:
                                 Steven L. Wasserman, Esq.
                           Paul, Hastings, Janofsky & Walker LLP
                                        399 Park Avenue
                                New York, New York  10022-4697
                                        (212) 318-6000

            Approximate date of commencement of proposed sale to the public:
    From time to time after the effective date of this Registration Statement.


     If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check the
following. ___

     If any of the securities being registered on this Form are to be offered
on a delayed or continuous basis pursuant to Rule 415 under the Securities Act
of 1933, other than securities offered only in connection with dividend or
interest reinvestment plans, check the following. X
                                                 ___

     If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. ___

     If this form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following and list the Securities Act
registration statement number of the earlier registration statement for the
same offering. ___

    If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following. ___




The information in this prospectus is not complete and may be changed.  These
securities may not be sold nor may offers to buy be accepted until this
Registration Statement filed with the Securities and Exchange Commission becomes
effective.  This prospectus is not an offer to sell these securities and is not
soliciting offers to buy these securities in any state where the offer or sale
is not permitted.



                            SUBJECT TO COMPLETION
               Preliminary Prospectus Dated July 19, 2000

                                 Prospectus

                              PHOTRONICS, INC.

                              1,000,000 Shares

                                Common Stock


                           -------------------------


The Selling Shareholders:  The selling shareholders identified in this
                           prospectus are selling 1,000,000 shares of the
                           common stock, par value $.01 per share, of
                           Photronics, Inc. ("Photronics" or the "Company"),
                           which were sold to the selling shareholders by us
                           in a private financing.

                           We are not selling any shares of our common stock
                           under this prospectus and will not receive any of
                           the proceeds from the sale of shares by the
                           selling shareholders.

Offering Price:            The selling shareholders may sell the shares of
                           common stock described in this prospectus in a
                           number of different ways and at varying prices.
                           We provide more information about how the selling
                           shareholders may sell their shares in the section
                           titled "Plan of Distribution" on page -.

Trading Market:            Our common stock is listed on the Nasdaq National
                           Market under the symbol "PLAB."  On July 18, 2000,
                           the closing sale price of our common stock, as
                           reported on the Nasdaq National Market, was
                           $28.00 per share.

Risks:                     Investing in our common stock involves certain
                           risks.  See "Risk Factors" beginning on page _____.


The shares offered or sold under this prospectus have not been approved by
the Securities and Exchange Commission or any state securities commission,
nor have these organizations determined that this prospectus is accurate or
complete.  Any representation to the contrary is a criminal offense.

                          The date of this prospectus is July --, 2000


                                   SUMMARY

     We are a leading manufacturer of photomasks, which are used primarily by
the semiconductor industry in the manufacture of integrated circuits.  Based
upon available market information, we believe that Photronics is one of the
largest photomask manufacturers in the world.

     Photronics' principal executive offices are located at 1061 East Indiantown
Road, Jupiter, Florida 33477 (telephone (561) 754-1222).

                                  RISK FACTORS

     Prospective purchasers of the shares should consider carefully the
following risk factors relating to the offering and our business, together with
the information and financial data included or incorporated by reference in this
prospectus, prior to making an investment decision.

We may have difficulties in combining the operations of Photronics
and Align-Rite.

     In June, 2000, we completed our merger with Align-Rite International, Inc.
("Align-Rite"), a photomask manufacturer.  We may not be able to combine
successfully our operations and Align-Rite's. There are a large number of
systems that must be integrated including management information, purchasing,
accounting and finance, sales, billing and payroll and benefits. The integration
of Photronics and Align-Rite also will require significant attention from
management, possibly reducing its ability to focus on other operations or
projects. Any delays or increased costs of combining the two companies could
adversely affect Photronics and disrupt its operations. As a result of the
merger, Photronics and/or Align-Rite may experience the loss of key personnel.

We depend on demand for integrated circuit design activity by the semiconductor
industry, which fluctuates.

     We sell substantially all of our photomasks to semiconductor designers and
manufacturers. We believe that the demand for photomasks primarily depends on
integrated circuit design activity rather than the volume of semiconductor
sales. Consequently, an increase in semiconductor sales does not necessarily
result in a corresponding increase in photomask sales.  In addition, the reduced
use of customized integrated circuits or other changes in the technology or
methods of manufacturing semiconductors could reduce demand for photomasks even
if demand for semiconductors increases.  Further, advances in semiconductor and
photomask design and semiconductor production methods could reduce the demand
for photomasks.  We cannot assure you that any of the preceding factors will not
have a material adverse effect on our business and results of operations.


We may experience fluctuations in our quarterly operating results.

     We have experienced fluctuations in our quarterly operating results and we
anticipate that such fluctuations will continue and could intensify in the
future.  Fluctuations in operating results may result in volatility in the price
of our common stock.  Our operating results may fluctuate as a result of many
factors, including:

     -   size and timing of orders and shipments;
     -   loss of significant customers;
     -   product mix;
     -   technological change;
     -   competition; and
     -   general economic conditions.

     Our customers generally order our products on an as-needed basis, and
substantially all of our net sales in any quarter are dependent on orders
received during that quarter.  Since we operate with a limited backlog and the
rate of new orders may vary significantly from month to month, our capital
expenditures and expense levels are based primarily on sales forecasts.
Consequently, if anticipated sales in any quarter do not occur when expected,
capital expenditures and expense levels could be disproportionately high, and
our operating results would be adversely affected.  Due to these factors, we
believe that period-to-period comparisons of our operating results are not
necessarily meaningful and that such comparisons cannot be relied upon as
indicators of future performance.  In addition, in some future quarters our
operating results could be below the expectations of public market analysts and
investors, which, in turn, could materially adversely affect the market price
of our common stock.

Rapid technological change may affect our operations.

     To remain competitive, we will be required to continually anticipate,
respond to and utilize changing technologies occurring within the photomask
industry.  In particular, we believe that as semiconductor geometries continue
to become smaller, we will be required to manufacture more technologically
advanced photomasks.  These technologies currently are in developmental stages
and we have not yet manufactured these types of photomasks in significant
volume.  In addition, demand for photomasks has been and could in the future be
adversely affected by changes in methods of semiconductor manufacturing, which
could affect the type or quantity of photomasks utilized, or increased market
acceptance of alternative methods of transferring circuit designs onto
semiconductor wafers which could reduce or eliminate the need for photomasks.
If we were unable to anticipate, respond to or utilize these or other changing
technologies, our business and results of operations could be materially
adversely affected.


Our operations require significant capital investments.

     The manufacture of photomasks requires a significant investment in fixed
assets.   We expect that we will be required to continue to make significant
capital expenditures to expand and improve our operations. If we cannot make
such expenditures, it could adversely affect our ability to satisfy customer
requirements.  We cannot assure you that we will be able to obtain any
additional capital on reasonable terms, or at all, or that any such expenditures
will not increase our costs without corresponding increases in revenues or net
income.

Photronics depends on major customers, the loss of which could adversely affect
its operating results and financial condition.

     Approximately 35% of Photronics' net sales in fiscal 1999 was derived from
sales to its five largest customers.  Although we have arrangements which assure
us a specified amount of some customers' requirements as long as our performance
is satisfactory, we generally do not have contracts requiring customers to
purchase any minimum quantity of photomasks.  Any loss of, or significant
reduction in, orders from any of these customers could have a material adverse
effect on Photronics' business and results of operations.

Photronics depends on major suppliers and the inability to obtain equipment or
raw materials when required could affect adversely its business and results of
operations.

     Photronics relies on a limited number of photomask equipment manufacturers
to develop and supply the equipment used in the photomask manufacturing
process.  Photronics uses significant manufacturing systems that usually are
built to order and typically have order lead times that can exceed one year.
Further, Photronics relies on equipment suppliers to develop future
generations of manufacturing systems to support its requirements.  The
inability to obtain equipment when required could have a material adverse
affect on our business and results of operations.

     Photronics uses high precision quartz photomask blanks, protective
transparent cellulose membranes and electronic grade chemicals in our
manufacturing processes.  Any delays or quality problems in connection with
significant raw materials, particularly photomask blanks, could cause delays in
shipments of photomasks which could adversely affect our business and results
of operations.  The fluctuation of foreign currency exchange rates with respect
to prices of significant raw materials used in manufacturing also could have a
material adverse affect on our business and results of operations, although they
have not been material to date.


Our acquisition strategy could place significant demands on our management and
systems.

     Photronics has rapidly expanded its operations, primarily by acquisitions
of existing photomask manufacturing operations.  This expansion has placed, and
will continue to place, significant demands on our administrative, operational
and financial personnel and systems.  Managing acquired operations, including
Align-Rite, entails numerous operational and financial risks, including
difficulties in the assimilation of acquired operations, diversion of
management's attention to other business concerns, amortization of acquired
intangible assets and potential loss of key employees of acquired operations.
Sales of acquired operations also may decline following an acquisition,
particularly if there is an overlap of customers served by us and the acquired
operation, and such customers transition to another vendor in order to ensure
a second source of supply.  In addition, we have experienced in the past, and
could experience in the future, difficulties and delays in ramping up new
production facilities.  Our failure to successfully manage our expanding
operations could have a material adverse effect on our business and results of
operations.

Our operations in international markets could pose risks.

     Sales in international markets account for significant portions of
Photronics' revenues and we plan to continue to expand our international
operations.  Revenues from international markets accounted for 22% of
Photronics' revenues for its fiscal year ended October 31, 1999. We believe that
achieving additional international sales in markets in which we have no
manufacturing presence requires us to develop, among other things, a local
presence in these markets.  Such  strategy requires a significant investment of
financial, management, operational and other resources.  In international
markets where we do not have a significant presence, existing independent
photomask suppliers have local presences and market share.  Accordingly, we
would likely experience competition as we expand to new markets which could
adversely affect our ability to establish a significant presence in the
international markets that we target.  In addition, existing and any new
operations outside the United States can be affected by:

     -   fluctuations in exchange rates;
     -   political and economic conditions in various countries;
     -   unexpected changes in regulatory requirements;
     -   tariffs and other trade barriers;
     -   difficulties in staffing and managing foreign operations; and
     -   longer accounts receivable payment cycles and potentially adverse tax
         consequences.

     To date, none of these factors has significantly affected our operations.
However, Photronics continues to consider expansion in international markets,
including into markets that have experienced economic instability in recent
years.  We cannot assure you that these factors will not have a material adverse
affect on our ability to generate sales outside the United States in our current
markets or in markets to which we choose to expand.  Consequently, these factors


may have a material adverse affect on our business and results of operations.

We depend on key personnel of Photronics and Align-Rite.

     Our success, in part, depends upon key managerial, engineering and
technical personnel, as well as our ability to continue to attract and retain
additional personnel.  The loss of key personnel could have a material adverse
affect upon our business and results of operations.  The photomask industry
depends on the ability to provide to customers prompt and cost effective
service.  Customers frequently require that orders be filled within 24 hours of
being placed.  The loss of sales personnel to competitors could result in the
loss of revenues.  The loss of engineering and technical personnel could
diminish manufacturing efficiency.  We cannot assure you that Photronics can
retain its key managerial, sales, engineering and technical employees and those
of Align-Rite or that we can attract similar skilled employees in the future.

Forward-looking statements

     Several statements about Photronics contained in this prospectus, including
statements containing the words "believes", "anticipates", "intends", "expects",
and words of similar import, constitute "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934.  These forward-looking statements involve
numerous known or unknown risks, uncertainties and other factors that may cause
the actual results, performance or achievements to be materially different from
any future results, performance or achievements expressed or implied by such
forward-looking statements.  Important factors that could cause actual results
to differ materially from those in forward looking statements, many of which are
beyond the control of Photronics include:

     -   general economic and business conditions, both nationally and
         internationally and including in those localities in which Photronics
         operates manufacturing facilities;
     -   uncertain demand for photomasks and the cyclical nature of the
         semiconductor industry;
     -   rapid technological changes;
     -   competition;
     -   the need for capital to fund expansion;
     -   the ability to manage expanding operations;
     -   dependence on customers and suppliers; and
     -   other factors referenced in this proxy statement/prospectus or in our
         reports incorporated by reference.

     Given these uncertainties, you are cautioned not to place undue reliance
on such forward-looking statements.  We disclaim any obligation to update any
such factor or to publicly announce the results of any revisions to any of the
forward-looking statements contained here to reflect future events or
developments.


                     WHERE YOU CAN GET MORE INFORMATION

     We are a reporting company and file annual, quarterly and current reports,
proxy statements and other information with the Securities and Exchange
Commission ("SEC").  You may read and copy these reports, proxy statements
and other information at the SEC's public reference rooms in Washington, D.C.
(450 Fifth Street, N.W.), New York, New York and Chicago, Illinois.  You can
request copies of these documents by writing to the SEC and paying a fee for
the copying cost.  Please call the SEC at 1-800-SEC-0330 for more information
about the operation of the public reference rooms.  Our SEC filings are also
available at the SEC's web site at "http://www.sec.gov."  In addition, you
can read and copy our SEC filings at the office of the National Association
of Securities Dealers, Inc. at 1735 " K" Street, Washington, DC 20006.

     The SEC allows us to "incorporate by reference" information that we file
with them, which means that we can disclose important information to you by
referring you to those documents. The information incorporated by reference
is an important part of this prospectus, and information that we file later
with the SEC will automatically update and supersede this information.  We
incorporate by reference the documents listed below and any future filings we
will make with the SEC under Section 13(a), 13(c), 14 or 15(d) of the
Securities Exchange Act of 1934:

     1.   Registration Statement on Form 8-A, dated March 31, 1987;
     2.   Annual Report on Form 10-K for the fiscal year ended
          October 31, 1999, as amended;
     3.   Quarterly Report on Form 10-Q for the fiscal quarter
          ended January 30, 2000;
     4.   Quarterly Report on Form 10-Q for the fiscal quarter
          ended April 30, 2000;
     5.   Current Report on Form 8-K, dated November 4, 1999;
     6.   Current Report on Form 8-K, dated November 29, 1999;
     7.   Current Report on Form 8-K, dated January 14, 2000;
     8.   Current Report on Form 8-K, dated February 22, 2000;
     9.   Current Report on Form 8-K, dated March 15, 2000;
    10.   Current Report on Form 8-K, dated March 28, 2000;
    11.   Current Report on Form 8-K, dated May 19, 2000;
    12.   Current Report on Form 8-K, dated May 31, 2000;
    13.   Current Report on Form 8-K, dated June 21, 2000; and
    14.   Current Report on Form 8-K/A dated June 30, 2000.

     In addition to these reports filed by Photronics, we are also
incorporating by reference into this prospectus the consolidated financial
statements for Align-Rite and the notes thereto contained in Item 8 of Align-
Rite's form 10-K for the fiscal year ended March 31, 1999 filed with the SEC.


     You may request a copy of these filings at no cost, by writing, telephoning
or e-mailing us at the following address:

                       Photronics, Inc.
                       Investor Relations
                       15 Secor Road
                       Brookfield, CT 06804
                       Attention: Michael W. McCarthy
                       (203) 775-9000
                       e-mail:  mmccarthy@brk.photronics.com

     This prospectus is part of a Registration Statement we filed with the
SEC.  You should rely only on the information incorporated by reference or
provided in this prospectus and the Registration Statement.

                               USE OF PROCEEDS

     We will not receive any proceeds from the sale of common stock by the
selling shareholders in the offering.


                           SELLING SHAREHOLDERS

     In June, 2000, we sold to the selling shareholders common stock in a
private placement and agreed to register the common stock sold to those
selling shareholders for their resale. Our registration of the shares of
common stock does not necessarily mean that the selling shareholders will
sell all or any of the shares.

     The following table sets forth certain information regarding the beneficial
ownership of the common stock, as of June 29, 2000, by each of the selling
shareholders.

     The information provided in the table below with respect to each selling
shareholder has been obtained from such selling shareholder. Except as otherwise
disclosed below, none of the selling shareholders has, or within the past three
years has had, any position, office or other material relationship with
Photronics.  Because the selling shareholders may sell all or some portion of
the shares of common stock beneficially owned by them, we cannot estimate the
number of shares of common stock that will be beneficially owned by the selling
shareholders after this offering.  In addition, the selling shareholders may
have sold, transferred or otherwise disposed of, or may sell, transfer or
otherwise dispose of, at any time or from time to time since the date on which
they provided the information regarding the shares of common stock beneficially
owned by them, all or a portion of the shares of common stock beneficially owned
by them in transactions exempt from the registration requirements of the
Securities Act of 1933.


     Beneficial ownership is determined in accordance with Rule 13d-3(d)
promulgated by the SEC under the Securities Exchange Act of 1934. Shares of
common stock issuable pursuant to options, warrants and convertible securities,
to the extent such securities are currently exercisable or convertible within
60 days of June 29, 2000, are treated as outstanding for computing the
percentage of the person holding such securities but are not treated as
outstanding for computing the percentage of any other person. Unless otherwise
noted, each person or group identified possesses sole voting and investment
power with respect to shares, subject to community property laws where
applicable. Shares not outstanding but deemed beneficially owned by virtue of
the right of a person or group to acquire them within 60 days are treated as
outstanding only for purposes of determining the number of and percent owned by
such person or group.  Applicable percentages are based on 29,531,908 shares
outstanding on June 23, 2000, adjusted as required by rules promulgated by the
SEC.

                                   Number of        Number of
                                 shares of the     shares of the      Percent-
                                 common stock      common stock       age of
                                 owned prior       being offered      out-
Name                           to this offering    in this offering   standing
- ----                            ----------------   ----------------   --------

Prism Partners I                         63,000        63,000             *
Prism Partners I Offshore Fund            9,000         9,000             *
Prism Partners II Offshore Fund          18,000        18,000             *

NewCastle Partners LLC                   13,000        13,000             *
NewCastle Millennium                      6,000         6,000             *
NewCastle Millennium II                   1,000         1,000             *

CMC Small Cap Fund #6                   107,300        24,000             *
Columbia Small Cap Fund #8              196,350        60,100             *
CTC Small Stock Inv Fund #105            56,200        14,000             *
Hanford Oper & Eng #97                   40,600         8,900             *
Pitt. & Co.                              10,950         6,400             *
Teamsters Affiliate Pension #315         17,200         5,200             *
National Electric Pension #318           76,900        22,200             *
YMCA Retirement Fund #330                46,400         9,200             *

Prudential Small Company Value Fund     299,300       299,300          1.0%
Prudential Variable Contact Account-6   130,700       130,700             *

Formula Unit Trust                      165,750        80,000             *

Maple Row Partners L.P.                 100,000       100,000             *

Willow Creek Capital Partners, L.P.      50,000        50,000             *

Columbus Capital Partners, L.P.          70,000        70,000             *

McCain Family Trust                      10,000        10,000             *

- -----------------------------------------------------------

*  Less than 1% of the outstanding shares of common stock.


                            PLAN OF DISTRIBUTION

     The shares of common stock offered by the selling shareholders may be sold
from time to time to purchasers directly by any of the selling shareholders
acting as principal for its own account in one or more transactions at a fixed
price, which may be changed, or at varying prices determined at the time of sale
or at negotiated prices.  Alternatively, any of the selling shareholders may
from time to time offer the common stock through underwriters, dealers or agents
who may receive compensation in the form of underwriting discounts, commissions
or concessions from the selling shareholders and/or the purchasers of shares
for whom they may act as agent.  Sales may be made on the Nasdaq National
Market or in private transactions.  In addition to sales of common stock
pursuant to this Registration Statement of which this prospectus is a part,
the selling shareholders may sell such common stock in compliance with Rule
144 promulgated under the Securities Act of 1933.

     The selling shareholders and any agents, broker-dealers or underwriters
that participate in the distribution of the common stock offered hereby may be
deemed to be underwriters within the meaning of the Securities Act of 1933, and
any discounts, commissions or concessions received by them and any profit on the
resale of the common stock purchased by them might be deemed to be underwriting
discounts and commissions under the Securities Act of 1933.

    In order to comply with the securities laws of certain states, if
applicable, the common stock may be sold in such jurisdictions only through
registered or licensed brokers or dealers.  In addition, in certain states the
common stock may not be sold unless it has been registered or qualified for sale
or an exemption from registration or qualification requirements is available and
is complied with.

     We have agreed to register the selling shareholders' common stock under
applicable federal and state securities laws under certain circumstances and at
certain times. We will pay substantially all of the expenses incident to the
offering and sale of the common stock to the public, other than commissions,
concessions and discounts of underwriters, dealers or agents and fees of
advisors to the selling shareholders and transfer taxes. Such expenses
(excluding such commissions and discounts, fees and taxes) are estimated to be
$29,336. The agreements provide for cross-indemnification of the selling
shareholders and Photronics to the extent permitted by law, for losses, claims,
damages, liabilities and expenses arising, under certain circumstances, out of
any registration of the common stock.

                                LEGAL MATTERS

     The validity of the issuance of the common stock offered hereby will be
passed upon for Photronics by Paul, Hastings, Janofsky & Walker, LLP, Stamford,
Connecticut.


                                   EXPERTS

     The consolidated financial statements incorporated in this prospectus by
reference from the Photronics, Inc. Annual Report on Form 10-K for the year
ended October 31, 1999 have been audited by Deloitte & Touche LLP, independent
auditors, as stated in their report, which is incorporated herein by reference,
and has been so incorporated in reliance upon the report of such firm given upon
their authority as experts in accounting and auditing.

     The consolidated financial statements incorporated in this prospectus by
reference to the Annual Report on Form 10-K of Align-Rite International, Inc.
for the year ended March 31, 1999 have been so incorporated in reliance on the
reports of PricewaterhouseCoopers LLP, independent accountants, given on the
authority of said firm as experts in auditing and accounting.

     The supplementary consolidated financial statements of Photronics, Inc. and
subsidiaries (except the consolidated financial statements of Align-Rite
International, Inc. and subsidiaries as of March 31, 1998 and for the years
ended March 31, 1998 and 1997) as of October 31, 1999 and November 1, 1998, and
for each of the three years in the period ended October 31, 1999, incorporated
by reference from Photronics Inc. Form 8-K/A dated June 30, 2000 in this
prospectus have been audited by Deloitte & Touche LLP, as stated in their report
which is incorporated herein by reference. The supplementary consolidated
financial statements give retroactive effect to the merger of Photronics, Inc.
and Align-Rite International, Inc. which has been accounted for as a pooling-of-
interests.  The audited financial statements of Align-Rite International, Inc.,
and subsidiaries as of March 31, 1998 and for each of the two years in the
period ended March 31, 1998, not separately presented in this prospectus, have
been audited by PricewaterhouseCoopers LLP, independent accountants, whose
report thereon is incorporated by reference herein.  Such financial statements,
to the extent that they have been included in the supplementary financial
statements of Photronics, Inc., have been so included in reliance on the report
of such independent accountants given on the authority of said firm as experts
in auditing and accounting. All of the foregoing firms are independent auditors.



                              TABLE OF CONTENTS


                                                                      PAGE

Prospectus Summary....................................................

Risk Factors..........................................................

Where You Can Get More Information....................................

Use of Proceeds.......................................................

Selling Shareholders..................................................

Plan of Distribution..................................................

Legal Matters.........................................................

Experts...............................................................



                                   PART II

                 INFORMATION NOT REQUIRED IN PROSPECTUS

Item 14.  Other Expenses of Issuance and Distribution.

     The following table sets forth all expenses, other than the underwriting
discounts and commissions, payable by Photronics in connection with the sale of
the common stock being registered.  All the amounts shown are estimates except
for the registration fee.

     Registration Fee . . . . . . . . . . . . . . . . .$  7,186
     Printing and engraving expenses...................$    200
     Legal fees and expenses...........................$  5,000
     Accounting Fees and Expenses......................$ 10,000
     Miscellaneous.....................................$    500
     Nasdaq Additional Listing Fee.....................$  6,450
                                                       --------
     Total.............................................$ 29,336
                                                       ========

Item 15.  Indemnification of Directors and Officers.

     Under applicable Connecticut law, the Company shall provide for
indemnification of its directors, officers, employees and agents.  Applicable
Connecticut law requires the Company to indemnify a director against judgements
and other expenses of litigation when he is sued by reason of his being a
director in any proceeding brought, other than on behalf of the corporation, if
a director is successful on the merits in defense, or acted in good faith and
in a manner reasonably believed to be in the best interests of the corporation,
and in all other cases that his conduct was at least not opposed to the best
interests of the corporation, or in  a criminal action or proceeding, had no
reasonable cause to believe his conduct was unlawful.  In a proceeding brought
on behalf of a corporation (a derivative action), a director is entitled to be
indemnified by the corporation for reasonable expenses of litigation, if the
director is finally adjudged not to have breached his duty to the corporation.
In addition, a director is entitled to indemnification for both derivative and
non-derivative actions, if a court determines, upon application, that the
director is fairly and reasonably entitled to be indemnified.  Finally, the
Company maintains director and officer liability insurance which provides
insurance for the Company's directors and officers in connection with claims
brought against them in their capacity as such with the Company.

     Article Ninth of the Company's Certificate of Incorporation limits
directors' monetary liability for actions or omissions made in good faith, which
are later determined to be a breach of their duty as directors of the Company.
Article Ninth does not eliminate or limit a director's liability for breaches
of fiduciary duty for actions or omissions which (i) involved a knowing and
culpable violation of law; (ii) enabled a director or an associate (as defined


under applicable law) to receive an improper personal economic gain; (iii)
showed a lack of good faith and conscious disregard for his duty as a
director under circumstances where the director was aware that his actions
created an unjustifiable risk of serious injury to the Company; (iv)
constituted a sustained and unexcused pattern of inattention that amounted
to an abdication of his duty; or (v) involved the improper distribution of
Company assets to its shareholders or an improper loan to an officer,
director or 5% shareholder. Article Ninth also does not preclude suits for
equitable relief, such as an injunction, nor would it shield directors from
liability for violations of the federal securities laws.  Moreover, Article
Ninth does not limit the liability of directors for any act or omission that
occurred prior to the date the Article became effective and does not limit
the potential liability of officer-directors in their capacity as officers.

Item 16.  Exhibits.

     5.1   -  Opinion of Paul, Hastings, Janofsky and Walker LLP
    23.1   -  Consent of PricewaterhouseCoopers LLP
    23.2   -  Consent of Deloitte & Touche LLP
    23.3   -  Consent of Paul, Hastings, Janofsky and Walker LLP
              (included in Exhibit 5.1)

Item 17.  Undertakings.

(a)  Rule 415 offerings.

     The undersigned registrant hereby undertakes:

     (i)   to file, during any period in which offers or sales are being made,
           a post-effective amendment to this Registration Statement to include
           any material information with respect to the plan of distribution
           not previously disclosed in this Registration Statement or any
           material change to such information in this Registration Statement;

    (ii)   that, for the purpose of determining any liability under the
           Securities Act of 1933, each such post-effective amendment shall be
           deemed to be a new registration statement relating to the securities
           offered therein, and the offering of such securities at that time
           shall be deemed to be the initial bona fide offering thereof; and

   (iii)   to remove from registration by means of a post-effective amendment
           any of the securities being registered which remain unsold at the
           termination of the offering.


(b)  Filings incorporating subsequent Exchange Act documents by reference.

     The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act, each filing of the
registrant's annual report pursuant to Section 13(a) or 15(d) of the Exchange
Act that is incorporated by reference in this Registration Statement shall be
deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.

(c)  Registration Statement Permitted by Rule 430A

     The undersigned Registrant hereby undertakes that:

    (1)    For purposes of determining any liability under the Securities Act,
           the information omitted from the form of prospectus filed as part of
           this Registration Statement in reliance upon Rule 430A and contained
           in a form of prospectus filed by the registrant pursuant to Rule
           424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed
           to be part of this Registration Statement as of the time it was
           declared effective.

     (2)   For the purpose of determining any liability under the Securities
           Act, each post-effective amendment that contains a form of prospectus
           shall be deemed to be a new registration statement relating to the
           securities offered therein, and the offering of such securities at
           that time shall be deemed to be the initial bona fide offering
           thereof.

(d)  Request for acceleration of effective date.

     Insofar as indemnification for liabilities arising under the Securities Act
may be permitted to directors, officers and controlling persons of the
registrant pursuant to provisions described in Item 15, or otherwise, the
registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the
Securities Act and is, therefore, unenforceable.  In the event that a claim for
indemnification against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer or controlling


person of the registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities
Act and will be governed by the final adjudication of such issue.



                                  SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the Town of Brookfield, State of Connecticut, on the 18th day
of July, 2000.

                                            PHOTRONICS, INC.


                                            By /s/ JEFFREY P. MOONAN
                                            ------------------------
                                            Jeffrey P. Moonan
                                            Executive Vice President


     Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.


Signature                              Title                    Date
- ---------                              -----                    ----

      *                            Chairman of the Board of     July 18, 2000
- --------------------------         Directors and Director
Constantine S. Macricostas

      *                            Vice Chairman of the Board   July 18, 2000
- ------------------                 and Director
Michael J. Yomazzo

      *                            President                    July 18, 2000
- ----------------                   (Principal Executive Officer)
James R. Northup

/s/ JEFFREY P. MOONAN              Vice President, Finance      July 18, 2000
- ---------------------              and Administration
Jeffrey P. Moonan                  (Principal Executive Officer)

      *                            Vice President/Finance and   July 18, 2000
- ---------------                    Chief Financial Officer
Robert J. Bollo                    (Principal Financial and
                                   Accounting Officer)

      *                            Director                     July 18, 2000
- ---------------------
Walter M. Fiederowicz

      *                            Director                     July 18, 2000
- ----------------------
Joseph A. Fiorita, Jr.
Director

      *                            Director                     July 18, 2000
- ---------------
Willem D. Maris


- -------------------------

*  By:  Jeffrey P. Moonan
        Attorney-In-Fact


                                EXHIBITS INDEX


Exhibit No.                          Description
- -----------                          -----------

   5.1                               Opinion of Paul, Hastings, Janofsky &
                                     Walker LLP

  23.1                               Consent of PricewaterhouseCoopers LLP

  23.2                               Consent of Deloitte & Touche LLP

  23.3                               Consent of Paul, Hastings, Jaonfsky &
                                     Walker LLP (included in Exhibit 5.1)


EXHIBIT 23.1

CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the incorporation by reference in this Amendment No. 1 to
Registration Statement on Form S-3 of Photronics, Inc. (file No. 333-40712)
of our reports dated May 28, 1999 relating to the financial statements and
financial statement schedule, which appears in Align-Rite International,
Inc.'s Annual Report on Form 10-K for the year ended March 31, 1999 and of
our report dated May 28, 1998 relating to the financial statements of
Align-Rite International, Inc., as of March 31, 1998 and for the two years in
the period then ended (not separately presented therein), which appears in
the Current Report on Form 8-K/A Amendment No. 1 of Photronics, Inc. dated
June 30, 2000.  We also consent to the reference to us under the heading
"Experts."

/s/PricewaterhouseCoopers LLP
- -----------------------------
PricewaterhouseCoopers LLP
Newport Beach, California
July 14, 2000



EXHIBIT 23.2

INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference in Amendment No. 1 to
Registration Statement No. 333-40712 of Photronics, Inc. on Form S-3 of our
report dated December 6, 1999, except as to Footnote 15, as to which the date is
January 10, 2000, appearing in the Annual Report on Form 10-K of Photronics,
Inc. for the year ended October 31, 1999, and of our report dated June 19,
2000, appearing in the Form 8-K/A Amendment No. 1 of Photronics, Inc. dated
June 30, 2000, relating to the supplementary consolidated financial
statements of Photronics, Inc. We also consent to the reference to us under the
heading "Experts" in the prospectus, which is part of this Registration
Statement.

/s/ Deloitte & Touche LLP
- -------------------------
Deloitte & Touche LLP
Hartford, Connecticut

July 14, 2000


                                         July 19, 2000

Photronics, Inc.
1061 East Indiantown Road
Jupiter, FL 33477

Re:  Photronics, Inc. Registration Statement 333-40712 on Form S-3
     ("Registration Statement")

Ladies and Gentlemen:

     We are furnishing this opinion of counsel to Photronics, Inc., a
Connecticut corporation (the "Company"), for filing as Exhibit 5.1 to the
Registration Statement relating to the resale by the "Selling Shareholders"
(as defined in the Registration Statement) of up to 1,000,000 shares of the
Company's common stock, par value $0.1 per share (the "Shares").

     For purposes of rendering this opinion, we have examined the Certificate
of Incorporation, as amended, and Bylaws of the Company, and the originals, or
copies certified or otherwise identified to our satisfaction, of records of
corporate proceedings of the Company as made available to us by the Company,
certificates of public officials and of representatives of the Company, and
such other documents and records as we deemed necessary.  In such examination
we have assumed the genuineness of all signatures, the authenticity of all
corporate records and other documents submitted to us as originals and the
conformity to original documents of documents submitted to us as certified
or photostatic copies.

     Based upon our examination as aforesaid, and in reliance upon our
examination of such questions of law as we deemed relevant under the
circumstances, we are of the opinion that the Shares are validly issued, fully
paid and nonassessable.

     We express no opinion with respect to the applicability or effect of the
laws of any jurisdiction other than the laws of the State of
Connecticut Business Corporation Act.

     We hereby consent to the filing of this opinion of counsel as Exhibit
5.1 to the Registration Statement and to the reference to us contained in the
prospectus which forms part of the Registration Statement under the heading
"Legal Matters."  In giving the foregoing consent, we do not thereby admit
that we belong to the category of persons whose consent is required under
Section 7 of the Securities Act of 1933, as amended, or the rules and
regulations promulgated by the Securities and Exchange Commission thereunder.

                                     Very truly yours,


                                     /s/ PAUL, HASTINGS, JANOFSKY & WALKER LLP
                                     -----------------------------------------
                                     Paul, Hastings, Janofsky & Walker LLP